W
WAVEMAN · COMPANY
LODE · Comstock Inc.
> Ask across nine datasets ⌘K
LIVE
TEAM-0.32% 13F +439META+2.47% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV+4.49% 13F +693CRM+2.92% 13F +1,018CVNA-0.98% 13F +794TPL-0.71% 13F +444NET-4.47% 13F +710MSTR-1.35% 13F +526DELL+4.91% 13F +1,203CRWD+5.68% 13F +1,382ANET+1.22% 13F +1,323COIN+10.14% 13F +475TEAM-0.32% 13F +439META+2.47% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV+4.49% 13F +693CRM+2.92% 13F +1,018CVNA-0.98% 13F +794TPL-0.71% 13F +444NET-4.47% 13F +710MSTR-1.35% 13F +526DELL+4.91% 13F +1,203CRWD+5.68% 13F +1,382ANET+1.22% 13F +1,323COIN+10.14% 13F +475
← ALL COMPANIES

LODE

Comstock Inc.
PHARMA & BIOTECH · INDUSTRIAL ORGANIC CHEMICALS · CIK 0001120970
CLUSTER · 5 INSIDERSACTIVIST 13DC-SUITE BUYING · 2☆ WATCH
INSIDER NET · 180D
$4.4M
open-market buys minus sells, Form 4 codes P and S
INSIDER BUYERS · 180D
5
CONGRESS BUYERS · 1Y
0
FUNDS ADDED · QTR
67
13F, latest reported quarter
REVENUE GROWTH
-48.5%
XBRL, annual
NET MARGIN
-2772.3%
SEVEN FACTS, RANKED AGAINST THE SECTOR · RANK IS NOT A FORECAST
INSIDERS
net +$4.4M over 180 days
+$1.0M over 90 days
more than 94% of Pharma & Biotech
CONGRESS
no member of Congress has reported trading it
FUNDS
67 funds added or opened last quarter
more than 52% of Pharma & Biotech
REVENUE
-48.5% year over year
below 83% of Pharma & Biotech
MARGIN
-2772.3% net margin
below 95% of Pharma & Biotech
BUYBACKS
no share repurchases reported
SHORT
9.0% of shares outstanding short · 3.9 days to cover · settled 2026-07-31
more than 73% of Pharma & Biotech
THE SITUATION · EVERY LINE IS ONE RULE OVER ONE DATASET
5 insiders independently bought a net $4.4M — no planned sales are queued against it.
67 funds added or opened positions in the latest 13F quarter, of 108 holders.
MAK Capital Fund LP disclosed a 5%+ stake (8.1%) in the last six months.
The year, with the filings on it
Total return indexed to 100 over the last 12 months · every marker is a federal filing, placed at its date — hover any marker for the detail
TOTAL 12M RETURN +36.0%
+36.0%12M
-1%+33%+66%+100%2025-092025-102025-122026-032026-052026-072026-09 2026-05-13 · Pei Steven Yu-Tsung bought $1.2M2026-06-03 · Pei Steven Yu-Tsung bought $707.4K2026-06-02 · Pei Steven Yu-Tsung bought $630.7K2026-06-12 · Pei Steven Yu-Tsung bought $615.0K2026-06-11 · Pei Steven Yu-Tsung bought $409.0K2026-05-14 · Pei Steven Yu-Tsung bought $272.9K2026-06-01 · Pei Steven Yu-Tsung bought $108.4K2026-05-12 · DEGASPERIS CORRADO bought $101.2K2026-06-03 · SPENCE ROBERT bought $96.9K2026-03-30 · Drozdoff Leo M bought $84.0K2026-03-30 · Drozdoff Leo M bought $84.0K2026-06-03 · DEGASPERIS CORRADO bought $42.5K2026-06-03 · Drozdoff Leo M bought $28.8K2026-08-06 · DEGASPERIS CORRADO bought $22.1K2026-03-30 · Merrill Judd bought $11.4K2026-03-25 · MAK Capital Fund LP filed a 5%+ stake (8.1%)2026-03-25 · MAK CAPITAL ONE LLC filed a 5%+ stake (8.1%)2026-03-25 · Kaufman Michael A filed a 5%+ stake (8.1%)
INSIDER BUY13D/G STAKE
INDEXED RETURN, DIVIDEND-ADJUSTED — NOT A PRICE CHART · LARGE TRADES DRAWN FIRST WHEN A NAME FILES HEAVILY
Live price
Daily candles from TradingView, on their licence — no filings are marked on this one
WHY THIS NAME IS ON THE DESK
5 insiders reported buying shares.
The record shows a net $4.4M bought by insiders over 180 days, 67 funds added last quarter. Every figure is a federal filing, dated the day it became public.
Same sector, ranked by filing activity
Sector from the SEC's own SIC classification
Insider transactions
Form 4 purchases and sales (codes P and S) — grants, option exercises and preferred conversions excluded

Over the last 180 days, Comstock Inc. insiders bought a net $4.4M of stock across 30 Form 4 purchases and sales, with 5 insider(s) buying. Source: SEC Form 4 filings, as of 2026-09-05.

INSIDER
FILED
SHARES
VALUE
DEGASPERIS CORRADO
CEO
BUY
2026-08-06
7,250.0
$22.1K
Pei Steven Yu-Tsung
Director
BUY
2026-06-12
150,000.0
$615.0K
Pei Steven Yu-Tsung
Director
BUY
2026-06-11
100,000.0
$409.0K
SPENCE ROBERT
Director
BUY
2026-06-03
24,410.0
$96.9K
Pei Steven Yu-Tsung
Director
BUY
2026-06-03
180,000.0
$707.4K
30 TRANSACTIONS ON RECORD

Showing the most recent few. Create a free account to see 25 more transactions on record, the cross-source screener and CSV export. We store only your email address, and there is no password to create.

Institutional holders
13F · holdings as of the latest quarter funds have reported
Hood River Capital Management LLC
6,693,538.0 sh
$27.8M
MAK CAPITAL ONE LLC
5,190,177.0 sh
$21.6M
BlackRock, Inc.
4,232,460.0 sh
$17.6M
VANGUARD CAPITAL MANAGEMENT LLC
3,275,091.0 sh
$13.6M
Northern Right Capital Management, L.P.
2,246,637.0 sh
$9.3M
5%+ owners
13D = intent to influence · 13G = passive
MAK Capital Fund LP
ACTIVIST 13D · 2026-03-25
8.1%
MAK CAPITAL ONE LLC
ACTIVIST 13D · 2026-03-25
8.1%
Kaufman Michael A
ACTIVIST 13D · 2026-03-25
8.1%
FORM 144
No planned-sale notices
No insider has notified an intent to sell. This is the panel to watch after a run-up.
Fund concentration
N-PORT · funds ranked by how much of THEMSELVES they put in this stock — the conviction number 13F cannot show
Hood River New Opportunities Fund
$5.5M POSITION · AS OF 2026-03-31
0.8%
Ultra-Small Company Market Fund
$192.2K POSITION · AS OF 2026-03-31
0.2%
iShares Micro-Cap ETF
$530.4K POSITION · AS OF 2026-03-31
0.0%
1290 VT Micro Cap Portfolio
$37.6K POSITION · AS OF 2026-03-31
0.0%
Fidelity Flex Small Cap Index Fund
$36.6K POSITION · AS OF 2026-04-30
0.0%
Avantis U.S. Small Cap Equity Fund
$9.0K POSITION · AS OF 2026-02-28
0.0%
SEC N-PORT, MONTHLY WITH A ~60-DAY PUBLIC LAG · FUNDS ≥ $10M · % = SHARE OF THE FUND'S OWN BOOK
Executive pay vs shareholder return · Corrado De Gasperis
DEF 14A pay-versus-performance disclosure · both the headline pay and the SEC's mark-to-market figure, beside the return the company delivered and the return of the peer group it chose itself
FY
CEO TOTAL
ACTUALLY PAID
OTHER NEOs AVG
TSR
PEER TSR
2025
$559.1K
$559.1K
$410.4K
-49%
2024
$501.9K
$227.9K
$499.6K
+40%
2023
$550.8K
$687.3K
$742.0K
+90%
2022
$503.4K
$503.4K
$428.1K
-79%
TAGGED BY THE COMPANY UNDER SEC ITEM 402(v) · RETURN IS CUMULATIVE FROM THE START OF THE DISCLOSURE PERIOD · GREEN WHERE THE COMPANY BEAT ITS OWN PEER GROUP
Fundamentals
Annual figures from XBRL filings · pick a past date to see them exactly as the market knew them then — restatements and all
2025-122024-122023-122022-12
REVENUE$1.6M$3.0M$1.3M$178.2K
GROSS PROFIT$178.2K
OPERATING INCOME$-38.1M$-39.7M$-12.6M$-19.4M
NET INCOME$-43.2M$-53.4M$10.5M$-46.7M
EPS (DILUTED)-1.17-3.210.87-0.62
OPERATING CASH FLOW$-24.4M$-13.9M$-13.6M$-12.1M
CASH$17.0M$954.3K$3.8M$2.5M
LONG-TERM DEBT$0$8.4M$5.4M$6.1M
SEC XBRL · FISCAL-YEAR PERIODS · AS KNOWN ON 2026-09-05 · NOBODY ELSE SHOWS FUNDAMENTALS AS OF A PAST DATE
W WAVEMAN

Public filings, honestly analyzed. Official US government sources in one desk — every figure carries the date it was filed, and the methodology is published, backtest included.

SEC FORM 4FORM 13F 13D/GFORM 144XBRL STOCK ACTCONTRACTSFEC CFPBNRC
© 2026 WAVEMAN · SOURCE: SEC EDGAR & OFFICIAL GOVERNMENT DATA · NOT INVESTMENT ADVICE · CHART BY TRADINGVIEW · UPDATED 2026-09-05 ALL SYSTEMS LIVE FOR MACHINES →